- Home
- CRIS vs XBP Comparison
CRIS vs XBP Comparison
Compare CRIS & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- XBP
- Stock Information
- Founded
- CRIS 2000
- XBP 2020
- Country
- CRIS United States
- XBP United States
- Employees
- CRIS N/A
- XBP N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- XBP Business Services
- Sector
- CRIS Health Care
- XBP Consumer Discretionary
- Exchange
- CRIS Nasdaq
- XBP Nasdaq
- Market Cap
- CRIS 18.6M
- XBP 67.2M
- IPO Year
- CRIS 2000
- XBP N/A
- Fundamental
- Price
- CRIS $1.49
- XBP $0.59
- Analyst Decision
- CRIS Strong Buy
- XBP
- Analyst Count
- CRIS 2
- XBP 0
- Target Price
- CRIS $16.50
- XBP N/A
- AVG Volume (30 Days)
- CRIS 76.1K
- XBP 841.6K
- Earning Date
- CRIS 11-06-2025
- XBP 11-14-2025
- Dividend Yield
- CRIS N/A
- XBP N/A
- EPS Growth
- CRIS N/A
- XBP N/A
- EPS
- CRIS N/A
- XBP N/A
- Revenue
- CRIS $11,405,000.00
- XBP $148,332,000.00
- Revenue This Year
- CRIS $2.72
- XBP N/A
- Revenue Next Year
- CRIS $8.27
- XBP N/A
- P/E Ratio
- CRIS N/A
- XBP N/A
- Revenue Growth
- CRIS 12.24
- XBP 0.23
- 52 Week Low
- CRIS $1.02
- XBP $0.42
- 52 Week High
- CRIS $5.00
- XBP $2.56
- Technical
- Relative Strength Index (RSI)
- CRIS 40.22
- XBP 46.52
- Support Level
- CRIS $1.46
- XBP $0.50
- Resistance Level
- CRIS $1.68
- XBP $0.57
- Average True Range (ATR)
- CRIS 0.08
- XBP 0.06
- MACD
- CRIS -0.00
- XBP 0.01
- Stochastic Oscillator
- CRIS 13.64
- XBP 71.66
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About XBP XBP Europe Holdings Inc.
XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.